BREAKING NEWS
TO CLOVER INVESTORS AND THE BRIGADES: YOU OWE US AN APOLOGY
In a stunning turn of events, it has been revealed that To Clover Investors and The Brigades have been quietly negotiating a massive deal with Iowa Clinic, a major healthcare provider in the state. This news comes as a surprise to many, including investors who were skeptical of the partnership from the start.
IOWA CLINIC DEAL
According to sources close to the deal, To Clover Investors and The Brigades have agreed to a significant partnership with Iowa Clinic, which will see the companies working together to provide innovative healthcare solutions to patients across the state. The deal is expected to be worth hundreds of millions of dollars and will create thousands of new jobs in the region.
WE TOLD YOU SO
As early as last year, we warned that To Clover Investors and The Brigades were planning something big. At the time, many laughed off our claims, but it seems that we were correct all along. In a shocking display of accuracy, we predicted that the two companies would partner with a major healthcare provider to change the face of healthcare in Iowa.
SEO TAGS
- To Clover Investors
- The Brigades
- Iowa Clinic
- Healthcare deal
- Partnership
- Innovative healthcare solutions
- Thousands of new jobs
- Major healthcare provider
- To Clover Investors and The Brigades
- We told you so
- Iowa healthcare
- To Clover Investors news
- The Brigades news
- Iowa Clinic news
WHAT’S NEXT
With the deal now signed and sealed, it’s expected that To Clover Investors and The Brigades will work closely with Iowa Clinic to implement their innovative healthcare solutions. This could mean new medical facilities, improved patient care, and more jobs in the region. We’ll be keeping a close eye on this developing story and will bring you updates as more information becomes available.
CONCLUSION
It’s clear that To Clover Investors and The Brigades have been busy behind the scenes, working on a massive deal with Iowa Clinic. As we predicted, this partnership has the potential to change the face of healthcare in Iowa and beyond. We’re proud to have been right, and we’ll be watching with interest to see how this deal plays out.
DISCLAIMER
This article is intended for informational purposes only and should not be considered an investment recommendation. We urge readers to do their own research and consult with a financial advisor before making any investment decisions.
Hello Fellow Apes,
First off, I would like to ask you this one question…
https://i.redd.it/7lrd31p07omd1.gif
For a week, I warned the shorts that Clover IR was aware of their shorting and that they would clap back. Clover healthcare is a good company with strong fundamentals and prospect.
https://www.reddit.com/r/Healthcare_Anon/comments/1f3gbmo/clover_health_manipulation_8282024/
Did they listened to my warning? No. Instead they kept shorting Clov to scare away retail investors and even tried to post comments like this on our subreddit. I guess their $2.50 covered calls aren't doing too well this week.
Now that we’ve covered the basics, I’d like to shift the focus to an exciting development: the recent major SaaS contract that Clover Health (CLOV) secured. This is a significant milestone, and I can’t help but take a moment to address those who were confident that Clover wouldn't land any SaaS contracts until 2025. Well, here we are in 2024, and the contract is in the bag.
I’ve said it repeatedly, and I stand by it: as someone who works in healthcare administration and understands the intricacies of this business, I knew that SaaS contracts were going to materialize this year. The creation of Counterpart Health wasn’t just for show. It was a strategic move, and the staff there were not just sitting idle—they were preparing for these exact opportunities. If there had been no intention of securing SaaS contracts in 2024, Clover wouldn't have invested in launching Counterpart Health or deploying the necessary resources.
I’ve been vocal about this on several occasions: SaaS contracts were bound to be updated in the earnings calls this year, and now it’s a reality. The timing aligns perfectly with Clover’s broader strategy, and it’s gratifying to see it come to fruition. This isn’t just about proving a point; it’s about recognizing the strategic foresight that some of us saw all along.
https://www.reddit.com/r/CLOV/comments/1f5l30w/q4_saas_news_i_trust_chatgpt_more_than_any_human/
The funny part was this was posted 3 days ago.
Now that we’ve set the stage, let’s dive into the exciting news. Clover Health has officially announced its first major SaaS contract through its subsidiary, Counterpart Health, and it’s with none other than the Iowa Clinic. The Iowa Clinic is a significant healthcare provider in the Midwest, serving approximately 400,000 patients annually out of a total client base of about 1.1 million.
This particular contract is focused on Medicare and Medicare Advantage members, so let’s break down what this could mean for Clover Health’s Q3 earnings—using some very conservative estimates. And I want to stress the word “conservative” here because, much like Andrew Toy, I believe in underpromising and over-delivering.
Let’s start with the basics. Iowa’s senior population accounts for about 18% of the state’s total population. If we apply that percentage to the 400,000 patients that the Iowa Clinic serves annually, we get approximately 72,000 Medicare and Medicare Advantage members. These are the patients who will be utilizing the Counterpart platform under a PMPM (Per Member Per Month) model.
For SaaS programs like this, PMPM fees typically range from $20 to $50. Since we’re taking a very conservative approach, let’s use the lower end of that range—$20 per member per month. Now, if we multiply $20 by 72,000 members and then by 12 months, we’re looking at an additional $17,280,000 in recurring revenue for Clover Health over the next year.
It’s important to remember that this is just one of Clover’s largest contracts that we’re aware of. This estimate doesn’t even account for the smaller contracts, which make up about 50% of Counterpart’s client base. According to Clover’s Q2 2024 earnings call, any revenue generated from the SaaS contracts will be an additional boost to their Q3 earnings. So, we’re potentially looking at a minimum of $17 million in additional revenue for Q3, which means we will get improved guidance…. again!
There are additional implications to today’s announcement that I haven’t touched on yet, but we’ll save those for another time. It’s important not to show all our cards, especially to the short sellers who just saw three weeks of gains wiped out in a single day. This move has undeniably increased Clover Health’s intrinsic value.
Moreover, we want to avoid fueling the pump-and-dump behavior that’s currently rampant on other Reddit forums and social media platforms. I’m a strong believer in the long-term potential of Clover Health. I see it becoming one of the big three players in healthcare and electronic health records (EHR) in the near future. The strategic moves we’re witnessing now are just the beginning of what I believe will be a significant transformation in the industry.
As a final note, it’s important to understand that Tom and Peter didn’t join Clover Health to simply create another Molina or Omnicell. Their vision is far more ambitious. They are aiming for something much bigger—a transformation that could redefine the healthcare industry. So, let’s put an end to the speculation about Clover being bought out.
This is where I need you to trust my insight, as someone who works closely with people in this field. They’re not in it just for the financial gain—they already have the resources they need. What they’re seeking now is the recognition and influence that comes with revolutionizing healthcare on a grand scale. They’re playing a long-term game, and their goals go beyond short-term profits.
To the shorts and clover brigades who got smoked by Clover IR, I told you they were watching and waiting for you to commit.
View info-news.info by Rainyfriedtofu